Abstract
Our aim was to evaluate the association of K121Q variant with T2DM in the Egyptian population. Genotyping of K121Q variant was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) for 212 subjects with T2DM and 170 normoglycemic subjects. The genotypes were KK, KQ, and QQ. Currently, the genotypes distribution and allele frequencies were significantly different between T2DM and control groups (p = 0.023, 0.005 respectively). The Q allele frequency was 32.59%, while the K allele frequency was 67.41% in total subjects. K121Q variant was associated with T2DM (OR = 1.52, 95% CI = 1.12–2.06) in an additive model of inheritance. Multiregression analysis was carried out to detect the effect of K121Q genotypes on lipid profile after adjustment for age, gender, and body mass index (BMI). The subjects with KQ or QQ genotype had significantly higher levels of low density lipoprotein-cholesterol (LDL-C) and total cholesterol (TC) and significantly lower levels of high density lipoprotein-cholesterol (HDL-C) in comparison to KK genotype either in the diabetic or in the control groups. Our findings revealed that K121Q variant is associated with T2DM in the Egyptian population in an additive model. Both KQ and QQ genotypes had an abnormal lipid profile in comparison to KK genotype in both diabetic and control groups.
Similar content being viewed by others
References
Hirschhorn JN, Altshuler D. Once and again issues surrounding replication in genetic association studies. J Clin Endocrinol Metab. 2002;87(10):4438–41. https://doi.org/10.1210/jc.2002-021329.
Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol. 2000;35(6):393–432. https://doi.org/10.1080/10409230091169249.
Goldfine ID, Maddux BA, Youngren J, Reaven G, Accili D, Trischitta V, et al. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev. 2008;29(1):62–75. https://doi.org/10.1210/er.2007-0004.
Maddux BA, Goldfine ID. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes. 2000;49(1):13–9. https://doi.org/10.2337/diabetes.49.1.13.
Pizzuti A, Frittitta L, Argiolas A Baratta R, Goldfine ID, Bozzali M, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999;48(9):1881–4. https://doi.org/10.2337/diabetes.48.9.1881.
Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, Vigneri R, et al. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes. 2001;50(4):831–6. https://doi.org/10.2337/diabetes.50.4.831.
Kubaszek A, Markkanen A, Eriksson JG, Forsen T, Osmond C, Barker DJ, et al. The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth. J clin Endocrinol Metab. 2004;89(5):2044–7. https://doi.org/10.1210/jc.2003-031350.
Wang R, Zhou D, Xi B, Ge X, Zhu P, Wang B, et al. ENPP1/PC-1 gene K121Q polymorphism is associated with obesity in European adult populations: evidence from a meta-analysis involving 24,324 subjects. Biomed Environ Sci. 2011;24(2):200–6.
Sortica DA, Buffon MP, Souza BM, Nicoletto BB, Santer A, Assmann TS, et al. Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysis. PLoS One. 2015;10(3):e0118416. https://doi.org/10.1371/journal.pone.0118416.
Hamaguchi K, Terao H, Kusuda Y, Yamashita T, Hazoury Bahles JA, Cruz LM, et al. The PC-1 Q121 allele is exceptionally prevalent in the Dominican Republic and is associated with type 2 diabetes. J clin Endocrinol Metab. 2004;89(3):1359–64. https://doi.org/10.1210/jc.2003-031387.
Morrison JA, Gruppo R, Glueck CJ, Stroop D, Fontaine RN, Wang P, et al. Population-specific alleles: the polymorphism (K121Q) of the human glycoprotein PC-1 gene is strongly associated with race but not with insulin resistance in black and white children. Metabolism. 2004;53(4):465–8. https://doi.org/10.1016/j.metabol.2003.10.029.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160–7. https://doi.org/10.2337/diacare.26.11.3160.
World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000.
Josef S, David WR, Nina I, Kaaren AJ. Molecular cloning: rapid isolation of mammalian DNA. New York: Cold Spring Harbour Laboratory Press; 2002. p. 628–30.
Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–9. https://doi.org/10.1093/bioinformatics/btl268.
Tang ST, Shen XR, Tang HQ, Wang CJ, Wei W, Zhang Q, et al. Association of the ENPP1 K121Q polymorphism with susceptibility to type 2 diabetes in different populations: evidence based on 40 studies. Endocr J. 2014;61(11):1093–103. https://doi.org/10.1507/endocrj.EJ14-0272.
El Achhab Y, Meyre D, Bouatia-Naji N, Berraho M, Deweirder M, Vatin V, et al. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population. Diabetes Metab. 2009;35(1):37–42. https://doi.org/10.1016/j.diabet.2008.06.005.
Ezzidi I, Mtiraoui N, Cauchi S, Vaillant E, Dechaume A, Chaieb M, et al. Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. BMC Med Gen. 2009;10(1):33. https://doi.org/10.1186/1471-2350-10-33.
Bouhaha R, Meyre D, Kamoun HA, Ennafaa H, Vaillant E, Sassi R, et al. Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population. Diabetes Res Clin Pract. 2008;81(3):278–83. https://doi.org/10.1016/j.diabres.2008.06.004.
Chandalia M, Grundy SM, Adams-Huet B, Abate N. Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas heart study cohort. J Diabetes Complicat. 2007;21(3):143–8. https://doi.org/10.1016/j.jdiacomp.2006.11.003.
Mtiraoui N, Turki A, Nemr R, Echtay A, Izzidi I, Al-Zaben GS, et al. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes Metab. 2012;38(5):444–9. https://doi.org/10.1016/j.diabet.2012.05.002.
Keshavar P, Inoue H, Sakamoto Y, Kunika K, Tanahashi T, Nakamura N, et al. No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population. J Hum Genet. 2006;51(6):559–66. https://doi.org/10.1007/s10038-006-0399-0.
Bhatti JS, Bhatti GK, Mastana SS, Ralhan S, Joshi A, Tewari R. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes in North Indians. Mol Cell Biochem. 2010;345(1–2):249–57. https://doi.org/10.1007/s11010-010-0579-2.
Saberi H, Mohammadtaghvaei N, Gulkho S, Bakhtiyari S, Mohammadi M, Hanachi P, et al. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population. Mol Cell Biochem. 2011;350(1–2):113–8.
Shi X, Wang L, Jin F, Sun J, Sun L, Tang L, et al. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes in northern Chinese. Acta Diabetol. 2011;48(4):303–10. https://doi.org/10.1007/s00592-011-0281-1.
Weedon MN, Shields B, Hitman G, Walker M, McCarthy MI, Hattersley AT, et al. No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K Caucasians. Diabetes. 2006;55(11):3175–9. https://doi.org/10.2337/db06-0410.
Maddux BA, Chang YN, Accili D, OP MG, Youngren JF, Goldfine ID. Over expression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol-Endocrinol Metab. 2006;290(4):746–9.
Zhou HH, Chin CN, Wu M, Ni W, Quan S, Liu F, et al. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Eur J Pharmacol. 2009;616(1):346–52. https://doi.org/10.1016/j.ejphar.2009.06.057.
Grundy SM. Small LDL atherogenic dyslipidemia and the metabolic syndrome. Circulation. 1997;95:1–4.
Tanyolaç S, Bremer AA, Hodoglugil U, Movsesyan I, Pullinger CR, Heiner SW, et al. Genetic variants of the ENPP1/PC1 gene are associated with hypertriglyceridemia in male subjects. Metab Syndr Relat Disord. 2009;7(6):543–8. https://doi.org/10.1089/met.2009.0027.
Moehlecke M, Kramer CK, Leitão CB, Krahe AL, Balbosco I, Azevedo MJ, et al. ENPP1 K121Q polymorphism and ischemic heart disease in diabetic patients. Arq Bras Cardiol. 2010;94:157–61.
Chen MP, Chung FM, Chang D, Tsai J, Huang HF, Shin SJ, et al. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev Diabet Stud. 2006;3(1):21–30. https://doi.org/10.1900/RDS.2006.3.21.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Mohamad, M.I., El Din Hemimi, N.S., El Salam, M.M.A. et al. K121Q variant in ENPP1 gene is associated with T2DM in the Egyptian population. Int J Diabetes Dev Ctries 38, 391–396 (2018). https://doi.org/10.1007/s13410-018-0609-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-018-0609-2